Butterfly Network, Inc.
BFLYButterfly Network, Inc. is a medical imaging company that develops portable ultrasound devices utilizing advanced ultrasound-on-chip technology. The company's flagship product, the Butterfly iQ, is a handheld, smartphone-connected ultrasound scanner designed to make medical imaging more accessible and affordable across healthcare settings worldwide.
Company News
AI-driven clinical intelligence is transforming medical imaging, with point-of-care diagnostics projected to reach $70.92 billion by 2032. The CMS ACCESS Model launching in July 2026 will reward outcome-based care, driving adoption of software-defined imaging platforms. Key players including VentriPoint Diagnostics, Butterfly Network, Hyperfine, ...
The Russell 2000 index reached an all-time high after the Federal Reserve signaled potential interest rate cuts, boosting small-cap stocks and providing cheaper borrowing opportunities for smaller companies.
The global AI in healthcare market is projected to reach nearly $700 billion by 2034, growing at 38.5% annually. Companies are developing advanced AI diagnostic technologies targeting areas like diabetic retinopathy, cardiac screening, and chronic disease management, with increasing FDA approvals and commercial potential.
Butterfly Network reported Q2 2025 results with 9% revenue growth, record 63.7% gross margin, and narrowed losses. The company revised full-year revenue guidance lower and is focusing on AI-driven software and international expansion.
The article discusses the rapid adoption of artificial intelligence (AI) in the healthcare industry, with several tech and biotech companies making significant strides. It highlights the potential of AI to transform various aspects of healthcare, including early disease detection and intelligent therapeutics.
